In order to understand whether the TRAIL-R pathway could be used to target TAM in the tumor micro-environment, we treated mice transplanted with the MN/MCA1 fibrosarcoma with recombinant TRAIL. The gene discussed is TNFSF10; the disease is neoplasm.